Found: 59
Select item for more details and to access through your institution.
A phase II study of tarloxotinib (a hypoxia activated prodrug of a pan-erb tyrosine kinase inhibitor) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or skin.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 4, p. 782, doi. 10.1007/s10637-022-01230-w
- By:
- Publication type:
- Article
Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 3, p. 257, doi. 10.1007/s10637-007-9098-8
- By:
- Publication type:
- Article
The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- Chemotherapy Research & Practice, 2012, p. 1, doi. 10.1155/2012/761518
- By:
- Publication type:
- Article
Skull base osteomyelitis in patients with head and neck cancer: Diagnosis, management, and outcomes in a case series of 23 patients.
- Published in:
- Laryngoscope Investigative Otolaryngology, 2022, v. 7, n. 1, p. 47, doi. 10.1002/lio2.719
- By:
- Publication type:
- Article
Development of investigational radiation modifiers.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Design and rationale of a prospective, multi-institutional registry for patients with sinonasal malignancy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Long-term outcomes of surgery followed by radiation therapy for minor salivary gland carcinomas.
- Published in:
- Laryngoscope, 2013, v. 123, n. 11, p. 2675, doi. 10.1002/lary.24081
- By:
- Publication type:
- Article
Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Follow-up on Programmed Cell Death 1 Inhibitor for Cutaneous Squamous Cell Carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma.
- Published in:
- JAMA Dermatology, 2015, v. 151, n. 9, p. 998, doi. 10.1001/jamadermatol.2015.0326
- By:
- Publication type:
- Article
In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation.
- Published in:
- PLoS ONE, 2023, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0276651
- By:
- Publication type:
- Article
Letter to the editor.
- Published in:
- Head & Neck, 1999, v. 21, n. 6, p. 582, doi. 10.1002/(SICI)1097-0347(199909)21:6<582::AID-HED14>3.0.CO;2-6
- By:
- Publication type:
- Article
A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 2, p. 201, doi. 10.1111/j.1365-2141.2008.07271.x
- By:
- Publication type:
- Article
The Clinical Application of Fluorescence-Guided Surgery in Head and Neck Cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.222810
- By:
- Publication type:
- Article
The Clinical Application of Fluorescence-Guided Surgery in Head and Neck Cancer.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 6, p. 758, doi. 10.2967/jnumed.118.222810
- By:
- Publication type:
- Article
Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141.
- Published in:
- Oncologist, 2022, v. 27, n. 2, p. e194, doi. 10.1093/oncolo/oyab036
- By:
- Publication type:
- Article
CheckMate 141: 1‐Year Update and Subgroup Analysis of Nivolumab as First‐Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1079, doi. 10.1634/theoncologist.2017-0674
- By:
- Publication type:
- Article
Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- Oncologist, 2018, v. 23, n. 7, p. 764, doi. 10.1634/theoncologist.2017-0618
- By:
- Publication type:
- Article
Commentary on "Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data".
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1022, doi. 10.1634/theoncologist.2017-0232
- By:
- Publication type:
- Article
Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck.
- Published in:
- Oncologist, 2015, v. 20, n. 12, p. 1393, doi. 10.1634/theoncologist.2015-0177
- By:
- Publication type:
- Article
Differentiated Thyroid Cancer: Focus on Emerging Treatments for Radioactive Iodine-Refractory Patients.
- Published in:
- Oncologist, 2015, v. 20, n. 2, p. 113, doi. 10.1634/theoncologist.2014-0313
- By:
- Publication type:
- Article
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Survival of patients with head and neck cancer treated with definitive radiotherapy and concurrent cisplatin or concurrent cetuximab: A Surveillance, Epidemiology, and End Results-Medicare analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of VK‐2019, a selective EBNA1 inhibitor.
- Published in:
- Biomedical Chromatography, 2024, v. 38, n. 2, p. 1, doi. 10.1002/bmc.5775
- By:
- Publication type:
- Article
Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 24, p. 4268, doi. 10.1002/cncr.28365
- By:
- Publication type:
- Article
Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 7, p. 1349, doi. 10.1002/cncr.27892
- By:
- Publication type:
- Article
Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeting CD137 enhances the efficacy of cetuximab.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Targeting CD137 enhances the efficacy of cetuximab.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 6, p. 2668, doi. 10.1172/JCI73014
- By:
- Publication type:
- Article
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 3, p. 1066, doi. 10.1172/JCI61226
- By:
- Publication type:
- Article
Assessing Care Value for Older Patients Receiving Radiotherapy With or Without Cisplatin or Cetuximab for Locoregionally Advanced Head and Neck Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Intraoperative Molecular Imaging for ex vivo Assessment of Peripheral Margins in Oral Squamous Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2020, v. 9, p. 1, doi. 10.3389/fonc.2019.01476
- By:
- Publication type:
- Article
Posttreatment FDG‐PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
- Published in:
- Head & Neck, 2022, v. 44, n. 11, p. 2491, doi. 10.1002/hed.27160
- By:
- Publication type:
- Article
Probe‐based fluorescence dosimetry of an antibody‐dye conjugate to identify head and neck cancer as a first step to fluorescence‐guided tissue preselection for pathological assessment.
- Published in:
- Head & Neck, 2020, v. 42, n. 1, p. 59, doi. 10.1002/hed.25964
- By:
- Publication type:
- Article
Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
- Published in:
- Head & Neck, 2017, v. 39, n. 5, p. 881, doi. 10.1002/hed.24692
- By:
- Publication type:
- Article
Hearing evaluation of patients with head and neck cancer: Comparison of Common Terminology Criteria for Adverse Events, Brock and Chang adverse event criteria in patients receiving cisplatin.
- Published in:
- Head & Neck, 2015, v. 37, n. 8, p. 1102, doi. 10.1002/hed.23714
- By:
- Publication type:
- Article
Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancer.
- Published in:
- Head & Neck, 2015, v. 37, n. 3, p. 386, doi. 10.1002/hed.23609
- By:
- Publication type:
- Article
Population-based evaluation of incidence trends in oropharyngeal cancer focusing on socioeconomic status, sex, and race/ethnicity.
- Published in:
- Head & Neck, 2014, v. 36, n. 1, p. 34, doi. 10.1002/hed.23253
- By:
- Publication type:
- Article
Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx.
- Published in:
- Head & Neck, 2011, v. 33, n. 1, p. 103, doi. 10.1002/hed.21406
- By:
- Publication type:
- Article
Higher incidence of head and neck cancers among Vietnamese American men in California.
- Published in:
- Head & Neck, 2010, v. 32, n. 10, p. 1336, doi. 10.1002/hed.21330
- By:
- Publication type:
- Article
Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-13076-7
- By:
- Publication type:
- Article
Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article